Brain Small Vessel Disease 4 (BSVD4): A Patient Guide
At a Glance
BSVD4 is a rare COL4A1-related condition caused by an AluYa5 insertion that can weaken small brain vessels. Care centers on individualized blood pressure control, careful medication decisions, avoiding head trauma, and monitoring neurological, eye, and kidney health.
This guide provides educational information about COL4A1-related cerebral small-vessel disease (specifically the AluYa5 subtype, often referred to as BSVD4) and does not replace individualized medical advice from your care team.
Brain Small Vessel Disease 4 (BSVD4) is a rare genetic condition that alters how the body builds and maintains its smallest blood vessels. It is caused by a specific genetic variation known as an AluYa5 insertion in the COL4A1 gene, which acts as a set of instructions for building collagen type IV. This collagen serves as the “scaffolding” or basement membrane that supports and strengthens vessel walls. In people with BSVD4, this genetic glitch is thought to alter the regulation of collagen production, which can weaken the vessel walls and make them more susceptible to injury [1].
Because this supportive scaffolding is found throughout the body, BSVD4 is considered a multisystem condition. While it most significantly affects the small vessels of the brain—leading to areas of small-vessel injury known as ischemic strokes, tiny leaks called microbleeds, or more significant hemorrhages—it can also involve the eyes and kidneys. This broader spectrum of symptoms is sometimes referred to as Gould Syndrome. Understanding that this is a systemic condition allows you and your medical team to look beyond neurological symptoms and proactively monitor the health of your vision and kidney function over time [2].
Living with BSVD4 requires a specialized approach to protective care. The most critical factor in this management is individualized blood pressure control, which generally helps reduce the physical “pressure” exerted on vulnerable vessel walls. Additionally, because the condition involves a unique risk of both bleeding and blockages, decisions regarding medications like aspirin or blood thinners must be highly individualized and should never be stopped or started without consulting your prescriber. Doctors also typically recommend avoiding activities that carry a high risk of head trauma, as even minor injuries can have more significant consequences for those with this genetic profile [3][4].
A diagnosis of BSVD4 provides a roadmap for long-term health rather than a definitive prediction of the future. The condition is known for its variable expressivity, meaning that the way it affects one person can be very different from how it affects another, even within the same family. By working with a multidisciplinary team—including neurologists, geneticists, and other specialists—you can establish a baseline of your health through specialized imaging and routine screenings. This proactive monitoring empowers you to manage the condition effectively, focusing on the modifiable risks and lifestyle adjustments that keep your vascular system as healthy as possible [5].
In this guide
6 chapters
Understanding Brain Small Vessel Disease 4 (BSVD4)
Learn what Brain Small Vessel Disease 4 (BSVD4) means, how the COL4A1 AluYa5 insertion affects brain vessels, inheritance, screening, and blood pressure care.
Symptoms and Emergency Warning Signs of BSVD4
Learn the chronic symptoms and emergency warning signs of BSVD4, including stroke, brain bleed, seizure, vision changes, and when to call for help safely.
The Genetics of BSVD4: COL4A1 and the Founder Mutation
Learn how the COL4A1 AluYa5 insertion causes BSVD4, including founder effect, inheritance, MRI findings, and differences from other small vessel diseases.
Imaging, Pathology, and Diagnosis of BSVD4
Learn how BSVD4 is diagnosed using brain MRI, AluYa5 insertion testing, and eye and kidney screening, including why standard genetic panels may miss it.
Standard of Care and Medical Management for BSVD4
Learn how BSVD4 care balances blood pressure control, blood-thinner decisions, safe activity, lifestyle changes, and eye and kidney monitoring for patients.
Building Your Care Team and Long-Term Monitoring
Learn how Brain Small Vessel Disease 4 (BSVD4) care teams coordinate MRI, eye, kidney, and blood-pressure monitoring, pregnancy planning, and long-term support.
Common questions in this guide
What is BSVD4 and what causes it?
What brain and body problems can BSVD4 cause?
How is BSVD4 managed and monitored over time?
Is it safe to take aspirin or a blood thinner with BSVD4?
What specialists should care for someone with BSVD4?
Does a BSVD4 diagnosis predict how severe the condition will be?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on brain small vessel disease 4.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Can you confirm my specific genetic mutation is the AluYa5 insertion in the COL4A1 gene?
- 2.What are your specific blood pressure targets for me based on my overall health?
- 3.Which specialists should be part of my core care team?
- 4.Given my imaging results, how should we weigh the risks and benefits of antiplatelet or blood-thinning medications?
- 5.What forms of aerobic and resistance exercise are safe and beneficial for me?
References
References (5)
- 1
An AluYa5 Insertion in the 3'UTR of COL4A1 and Cerebral Small Vessel Disease.
Aloui C, Neumann L, Bergametti F, et al.
JAMA network open 2024; (7(4)):e247034 doi:10.1001/jamanetworkopen.2024.7034.
PMID: 38630472 - 2
Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol.
Gasparini S, Balestrini S, Saccaro LF, et al.
American journal of medical genetics. Part C, Seminars in medical genetics 2024; (196(4)):e32099 doi:10.1002/ajmg.c.32099.
PMID: 39016117 - 3
Late-onset intracerebral hemorrhage associated with COL4A1 variants: clinical and genetic perspectives.
Zhuang X, Xu S, Chen C, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(1)):97.
PMID: 41484600 - 4
Updates on Prevention of Hemorrhagic and Lacunar Strokes.
Tsai HH, Kim JS, Jouvent E, Gurol ME
Journal of stroke 2018; (20(2)):167-179 doi:10.5853/jos.2018.00787.
PMID: 29886717 - 5
Main features of COL4A1-COL4A2 related cerebral microangiopathies.
Guey S, Hervé D
Cerebral circulation - cognition and behavior 2022; (3()):100140 doi:10.1016/j.cccb.2022.100140.
PMID: 36324412
This BSVD4 information is for education and does not replace medical advice. Discuss genetic testing, blood pressure targets, medications, exercise, and monitoring with your neurologist and genetic specialist.